![David W. Denning](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
David W. Denning
No open positions remaining
Profile
David W.
Denning was the founder of F2G Ltd. which was founded in 1998, where he held the title of Director.
Mr. Denning is also the founder of Myconostica Ltd. In his former jobs, he held the position of Principal at Stanford University from 1987 to 1990 and at The University of Manchester.
Former positions of David W. Denning
| Companies | Position | End |
|---|---|---|
Stanford University
 Stanford University Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | 01/01/1990 |
The University of Manchester
 The University of Manchester Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | - |
F2G Ltd.
 F2G Ltd. Pharmaceuticals: MajorHealth Technology Engages in research and development of novel drugs for life-threatening systemic fungal diseases treatment | Founder | - |
Myconostica Ltd.
 Myconostica Ltd. Electronic Equipment/InstrumentsElectronic Technology Develops molecular diagnostic fungal testing kits | Founder | - |
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
98
1st degree connections
4
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 4 |
|---|---|
Stanford University
Stanford University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The University of Manchester
The University of Manchester Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Myconostica Ltd.
Myconostica Ltd. Electronic Equipment/InstrumentsElectronic Technology Develops molecular diagnostic fungal testing kits | Electronic Technology |
F2G Ltd.
F2G Ltd. Pharmaceuticals: MajorHealth Technology Engages in research and development of novel drugs for life-threatening systemic fungal diseases treatment | Health Technology |
- Stock Market
- Insiders
- David W. Denning
